Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function

Journal of Virology

Volumn 71, Issue 8, 1997, Pages 5861-5870

  Bonin, Lisé R ^a,c   Mcdougall, James K ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DACTINOMYCIN; GENE PRODUCT; IMMEDIATE EARLY PROTEIN; PROTEIN P21; PROTEIN P53; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNOPRECIPITATION; NEWBORN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKIN FIBROBLAST;

EID: 0030741148     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.8.5861-5870.1997     Document Type: Article

References (72)

1. Baracchini, E., E. Glezer, K. Fish, R. M. Stenberg, J. A. Nelson, and P. Ghazal. 1992. An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator. Virology 188:518-529.
2. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461-468.
3. Biegalke, B. J., and A. P. Geballe. 1991. Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus. Virology 183:381-385.
4. Bischoff, F. Z., S. O. Yim, S. Pathak, G. Grant, M. J. Siciliano, B. C. Giovanella, L. C. Strong, and M. A. Tainsky. 1990. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 50:7979-7984.
5. Blanton, R. A., N. Perez-Reyes, D. T. Merrick, and J. K. McDougall. 1991. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am. J. Pathol. 138:673-685.
6. Bonin, L. R., and J. K. McDougall. Unpublished data.
7. Bresnahan, W. A., I. Boldogh, E. A. Thompson, and T. Albrecht. 1996. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224:150-160.
8. Chen, C.-Y., J. D. Oliner, Q. Zhan, A. J. Fornace, B. Vogelstein, and M. B. Kastan. 1994. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA 91:2684-2688.
9. Cherrington, J. M., E. L. Khoury, and E. S. Mocarski. 1991. Human cytomegalovirus ie2 negatively regulates a gene expression via a short target sequence near the transcription start site. J. Virol. 65:887-896.
10. Cherrington, J. M., and E. S. Mocarski. 1989. Human cytomegalovirus IE1 transactivates the a promoter-enhancer via an 18-base-pair repeat element. J. Virol. 63:1435-1440.
11. Choi, K. S., S.-J. Kim, and S. Kim. 1995. The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein. Virology 208:450-456.
12. Crook, T., N. J. Marston, E. A. Sara, and K. H. Vousden. 1994. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79:817-827.
13. Davis, M. G., S. C. Kenney, J. Kamine, and J. S. Pagano. 1987. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84:8642-8646.
14. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
15. Demers, G. W., S. A. Foster, C. L. Halbert, and D. A. Galloway. 1994. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus. Proc. Natl. Acad. Sci. USA 91:4382-4386.
16. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
17. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parson, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
18. Emery, V. C., and P. D. Griffiths. 1990. Current status review. Molecular biology of cytomegalovirus. Int. J. Exp. Pathol. 71:905-918.
19. Finlay, C. A., P. W. Hinds, T.-H. Tan, D. Eliyahu, M. Oren, and A. J. Levine. 1988. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol. 8:531-539.
20. Geist, L. J., M. M. Monick, M. F. Stinski, and G. W. Hunninghake. 1991. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes. Am. J. Respir. Cell. Mol. Biol. 5:292-296.
21. Gibson, W. 1993. Molecular biology of human cytomegalovirus, p. 303-329. In Y. Becker, G. Darai, and E.-S. Huang (ed.), Molecular aspects of human cytomegalovirus diseases. Springer-Verlag, New York, N.Y.
22. Griffiths, P. D., and J. E. Grundy. 1987. Molecular biology and immunology of cytomegalovirus. Biochem. J. 241:313-324.
23. Hagemeier, C., R. Caswell, G. Hayhurst, J. Sinclair, and T. Kouzarides. 1994. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13:2897-2903.
24. Hagemeier, C., S. Walker, R. Caswell, T. Kourzarides, and J. Sinclair. 1992. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early gene transactivates heterologous promoters in a TATA box-independent mechanism and interacts directly with TFIID. J. Virol. 66:4452-4456.
25. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66:2125-2134.
26. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
27. Hayhurst, G. P., L. A. Bryant, R. C. Caswell, S. M. Walker, and J. H. Sinclair. 1995. CCAAT box-dependent activation of the TATA-less human DNA polymerase a promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. J. Virol. 69:182-188.
28. Hendrix, M. G. R., M. Daemen, and C. A. Bruggeman. 1991. Cytomegalo-virus nucleic acid distribution within the human vascular tree. Am. J. Pathol. 138:563-567.
29. Hendrix, M. G. R., P. H. J. Dormans, P. Kitslaar, F. Busman, and C. A. Bruggeman. 1989. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am. J. Pathol. 134: 1151-1157.
30. Hendrix, M. G. R., M. M. M. Salimans, C. P. A. van Boven, and C. A. Bruggeman. 1990. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136:23-28.
31. Hermiston, G. P., C. L. Malone, and M. F. Stinski. 1990. Human cytomegalovirus immediate-early two-protein region involved in negative regulation of the major immediate-early promoter. J. Virol. 64:3532-3536.
32. Hiebert, S. W. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13:3384-3391.
33. Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of Rb with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:177-185.
34. Huang, E.-S., and T. F. Kowalik. 1993. The pathogenicity of human cytomegalovirus: an overview, p. 3-45. In Y. Becker, G. Darai, and E.-S. Huang (ed.), Molecular aspects of human cytomegalovirus diseases. Springer-Verlag, New York, N.Y.
35. Inman, G. J., and P. J. Farrell. 1995. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays. J. Gen. Virol. 76:2141-2149.
36. Jault, F. M., J.-M. Jault, F. Ruchti, E. A. Fortunato, C. Clark, J. Corbeil, D. D. Richman, and D. H. Spector. 1995. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69:6697-6704.
37. Jupp, R., S. Hoffmann, A. Depto, R. M. Stenberg, P. Ghazal, and J. A. Nelson. 1993. Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J. Virol. 67:5595-5604.
38. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
39. Kessis, T. D., R. J. Slebos, W. G. Nelson, M. B. Kastan, B. S. Plunkett, S. M. Han, A. T. Lorincz, L. Hedrick, and K. R. Cho. 1993. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 90:3988-3992.
40. Kraiss, S., A. Quaiser, M. Oren, and M. Montenarh. 1988. Oligomerization of oncoprotein p53. J. Virol. 62:4737-4744.
41. Lang, D., S. Gebert, H. Arlt, and T. Stamminger. 1995. Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J. Virol. 69:6030-6037.
42. Lemstrom, K. B., J. H. Bruning, C. A. Bruggeman, I. T. Lautenschlager, and P. J. Hayry. 1993. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J. Clin. Invest. 92:549-558.
43. Liu, B., T. W. Hermiston, and M. F. Stinski. 1991. A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2. J. Virol. 65:897-903.
44. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-936.
45. Malone, C. L., D. H. Vesole, and M. F. Stinski. 1990. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J. Virol. 64:1498-1506.
46. Margolis, M. J., S. Pajovic, E. L. Wong, M. Wade, R. Jupp, J. A. Nelson, and J. C. Azizkhan. 1995. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol. 69:7759-7767.
47. Melnick, J. L., E. Adam, and M. E. DeBakey. 1993. Human cytomegalovirus and atherogenesis, p. 80-91. In Y. Becker, G. Darai, and E.-S. Huang (ed.), Molecular aspects of human cytomegalovirus diseases. Springer-Verlag, New York, N.Y.
48. Melnick, J. L., C. Hu, J. Burek, E. Adam, and M. E. DeBakey. 1994. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42:170-174.
49. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:3391-3395.
50. Miller, A. D., M. A. Bender, E. A. Harris, M. Kaleko, and R. E. Gelinas. 1988. Design of retrovirus vectors for transfer and expression of the human beta-globin gene. J. Virol. 62:4337-4345.
51. Mocarski, E. S., G. W. Kemble, J. M. Lyle, and R. F. Greaves. 1996. A deletion mutant in the human cytomegalovirus gene encoding IE1 491aa is replication defective due to a failure in autoregulation. Proc. Natl. Acad. Sci. USA 93:11321-11326.
52. Muganda, P., O. Mendoza, J. Hernandez, and Q. Qian. 1994. Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J. Virol. 68:8028-8034.
53. Neumann, J. R., C. A. Morency, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques 5: 444-447.
54. Pizzorno, M. C., and G. S. Hayward. 1990. The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site. J. Virol. 64:6154-6165.
55. Poma, E. E., T. F. Kowalik, L. Zhu, J. H. Sinclair, and E.-S. Huang. 1996. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 70:7867-7877.
56. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
57. Roizman, B. 1991. Herpesviridae: a brief introduction, p. 841-847. In B. N. Fields (ed.), Fundamental virology. Raven Press, New York, N.Y.
58. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
59. Schwartz, R., B. Helmich, and D. H. Spector. 1996. CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J. Virol. 70:6955-6966.
60. Sommer, M. H., A. Scully, and D. H. Spector. 1994. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J. Virol. 68:6223-6231.
61. Sorlie, P. D., E. Adam, S. L. Melnick, A. Folsom, T. Skelton, L. E. Chambless, R. Barnes, and J. L. Melnick. 1994. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J. Med. Virol. 42:33-37.
62. Speir, E., R. Modali, E.-S. Huang, M. B. Leon, F. Shawl, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
63. Stenberg, R. M., J. Fortney, S. W. Barlow, B. P. Magrane, J. A. Nelson, and P. Ghazal. 1990. Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J. Virol. 64:1556-1565.
64. Tevethia, M. J., D. J. Spector, K. M. Leisure, and M. F. Stinski. 1987. Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters. Virology 161:276-285.
65. Wade, M., T. F. Kowalik, M. Mudryj, E.-S. Huang, and J. C. Azizkhan. 1992. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol. Cell. Biol. 12: 4364-4374.
66. Wassermann, K., J. Markovits, C. Jaxel, G. Capranico, K. W. Kohn, and Y. Pommier. 1990. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. Mol. Pharmacol. 38:38-45.
67. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
68. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
69. White, R., N. H. A. Terry, M. L. Meistrich, and D. P. Calkins. 1990. Improved method for computing potential doubling time from flow cytometric data. Cytometry 11:314-317.
70. Wu, X., H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 auto-regulatory feedback loop. Genes Dev. 7:1126-1132.
71. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Stron, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.
72. Zhu, H., Y. Shen, and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.